Company record · KLRS

Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc.'s chief financial officer on the record is Liisa Bayko, effective July 20, 2026, per the filing record.

Tracked changes

2026-07-20

Kalaris Therapeutics, Inc. appoints Liisa Bayko as CFO

This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.